RESULTS FOR : 'Kidney'
Showing 1 to 2 of 2 results |    
Keyword Search
Results Category/Section
RenaSci bolsters kidney disease and fibrosis capabilities with senior appointment

Leading in vivo pharmacology and consultancy services firm RenaSci, part of the Sygnature Group, have bolstered their Kidney Disease and Fibrosis capabilities with the appointment of Dr Wioletta Pijacka.

Developing The First Treatment For Acute Kidney Injury

Acute Kidney Injury (AKI) is a devastating disease characterised by a rapid loss of kidney function resulting in inability to maintain fluid, electrolyte and acidbase balance. AKI is particularly common in patients admitted to the Intensive Care Unit where incidence rates between 22% to as high as 67% of admissions have been reported.